It can be challenging to diagnose PAD without the aid of vascular testing
Boca Raton, FL (PRWEB) April 28, 2015
Wimbledon Health Partners, the leading on-site diagnostic testing organization which provides vascular, electrocardiogram, echocardiogram, and NCV testing, has expanded their network to provide on-site non-invasive vascular testing to help podiatrists diagnose peripheral arterial disease (PAD).
“It can be challenging to diagnose PAD without the aid of vascular testing,” said Bradley Artel M.D., F.A.C.C., Chief Medical Officer at Wimbledon Health Partners. “Diminished peripheral pulses, atrophic skin changes, and loss of hair are some classic findings, but are not always sensitive or specific indicators.”
Wimbledon Health Partners uses vascular ultrasound to diagnose a number of conditions. The turnkey on-site diagnostic program allows podiatrists to enhance their patient care by providing vascular and nerve conduction velocity (NVC) testing in their office. Patients appreciate the convenience and podiatrists appreciate the clinical data.
About Wimbledon Health Partners:
Wimbledon Health Partners was formed in response to the demand to attain on-site diagnostic testing capabilities for circulatory conditions. Furthering our capabilities, nerve conduction velocity testing (NCV) is also utilized to support diagnosis of nerve involvement and manage risk. Wimbledon Health Partners provides physicians with the educational, compliance, and marketing tools necessary to provide quality, state-of-the-art, in-office testing procedures. http://www.dxtesting.com (855) 200-8262